Regulatory Story
Go to market news section View chart   Print
RNS
GlaxoSmithKline PLC   -  GSK   

Total Voting Rights

Released 17:00 03-Sep-2018

RNS Number : 6291Z
GlaxoSmithKline PLC
03 September 2018
 

GlaxoSmithKline plc

 

Total Voting Rights and Capital

 

In conformity with the Financial Conduct Authority's Disclosure Guidance and Transparency Rule 5.6.1R, GlaxoSmithKline plc (the 'Company') hereby notifies the market of the following:

 

The Company's issued share capital as at 31 August 2018 consisted of 5,374,922,551 shares of 25 pence each ('Ordinary Shares'), of which 414,605,950 Ordinary Shares were held in Treasury.

 

Therefore, the total number of voting rights in the Company is 4,960,316,601. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

 

 

 

V A Whyte

Company Secretary

 

3 September 2018

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TVRUGUPABUPRGAW
Close


London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.

 


Total Voting Rights - RNS